CJC-1295 (No DAC) vs Ipamorelin — Peptide Comparison

CJC-1295 (No DAC) vs Ipamorelin — Peptide Comparison CJC-1295 (No DAC) vs Ipamorelin — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range CJC-1295 (No DAC) 100–300 mcg Ipamorelin Frequency Once daily Multiple times daily Administration Subcutaneous injection Cycle Length 8-12 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials (Phase 1-2) Efficacy GH Stimulation Sleep Quality Recovery Support GH Selectivity Safety Profile Technical Data Molecular Formula C152H252N44O42 Molecular Weight 3367.9 g/mol Half-Life 30 minutes to 2 hours Bioavailability ~100% (subcutaneous) CAS Number 863288-34-0 C38H49N9O5 711.85 g/mol 2 hours High when injected subcutaneously 170851-70-4 Protocols starting 100 mcg Once daily, 30 minutes before bed 2-4 weeks A common starting dose used in research practice. Because the no-DAC form is short-acting (about 30 minute half-life), it is injected on an empty stomach for the best growth-hormone pulse. [1] standard 100 mcg per dose 1-2 times daily The typical maintenance dose used in practice, often given before bed and/or after fasted exercise. Frequently paired with a GH-releasing peptide. [1] advanced 2-3 times daily A higher-frequency plan used by experienced users to mimic natural GH pulses across the day, each dose taken fasted. [1] 100 mcg per injection 4-8 weeks Conservative entry dose; Ipamorelin is a selective GH secretagogue with a ~2 hour half-life, so doses are split through the day [1][2]. Used in research and practice to assess tolerance before titrating up. 200 mcg per injection Most commonly cited research/practice dose; gives a meaningful pulsatile GH release without raising cortisol or prolactin at standard doses [1][2]. 300 mcg per injection 3 times daily Upper end of the commonly used range; total daily exposure split across three injections. Used in practice by experienced users [1]. Applications Natural Growth Hormone Optimization Perfect for those wanting to boost their body's own GH production rather than using synthetic growth hormone. Mimics the natural pulsatile release pattern your pituitary uses. Workout Recovery and Muscle Building Athletes and fitness enthusiasts use it to accelerate recovery between training sessions, support lean muscle development, and reduce body fat over time. Sleep Quality Enhancement Because GH is naturally released during deep sleep, many users report dramatically improved sleep quality with more vivid dreams and feeling more refreshed upon waking. Anti-Aging and Vitality As GH levels decline with age, CJC-1295 helps restore more youthful hormone patterns, potentially improving skin quality, energy levels, and overall well-being. Synergistic Peptide Stacking Designed to work hand-in-hand with GHRPs like Ipamorelin. When combined, these peptides amplify each other's effects for significantly greater GH release than either alone. Clean GH Boost Seekers If you want the benefits of increased growth hormone without spiking cortisol or other stress hormones, Ipamorelin is uniquely selective. Unlike GHRP-2 or GHRP-6, it won't raise your cortisol levels even at doses 200 times higher than needed for GH release. Recovery-Focused Athletes Ipamorelin shines for athletes who want better recovery between training sessions. The GH boost helps repair muscle tissue faster, and since it doesn't mess with other hormones, you can use it consistently without the rollercoaster effects. Anti-Aging Enthusiasts Growth hormone naturally declines as we age, contributing to muscle loss, fat gain, and reduced vitality. Ipamorelin offers a gentle way to restore more youthful GH levels without the risks of actual HGH therapy. Those Recovering from Steroid Use Research shows Ipamorelin can help counteract the muscle and bone-weakening effects of glucocorticoid medications. If you've been on steroids for medical reasons, this peptide may help you rebuild what you've lost. Common Injection site reactions Flushing or warmth Water retention Increased appetite Uncommon Tingling or numbness Headache Serious Allergic reaction Mild headache Tingling in hands or feet Joint stiffness Research Status FDA Status Research compound Safety Overview CJC-1295 without DAC has been studied in Phase 1-2 human clinical trials with a favorable safety profile. The most common side effects are mild and include injection site reactions and temporary flushing. Because it stimulates natural GH release rather than providing exogenous GH, it maintains the body's feedback mechanisms. Contraindications xActive cancer or history of cancer xPregnancy or breastfeeding xPituitary tumors or disorders xHypersensitivity to GHRH analogs xDiabetic retinopathy Ipamorelin has shown a favorable safety profile in both animal and human studies. What makes it stand out is its remarkable selectivity—it releases growth hormone without significantly affecting cortisol, ACTH, or other hormones. In clinical trials, it was well-tolerated with mostly mild, temporary side effects. Phase 2 trials in patients recovering from surgery showed no significant safety concerns compared to placebo. xPituitary disorders or tumors xKnown allergy to peptide components xChildren and adolescents (growth plates still open) Decision Guide Choose CJC-1295 (No DAC) if... Increasing natural growth hormone levels Building lean muscle mass Improving sleep quality Enhancing workout recovery Choose Ipamorelin if... Muscle recovery and growth Anti-aging and vitality Body composition improvement Sleep quality enhancement